EUVIMEDEUVIMED entdecken
Open Access

Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice

Izabela Tuleta, Anis Hanna, Claudio Humeres, Jennifer T Aguilan, Simone Sidoli, Fenglan Zhu, Nikolaos G Frangogiannis iD

Cardiovascular Research · 14.12.2024 · 120 (16) · 2047-2063

DOI: 10.1093/cvr/cvae210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 07.10.2024. Verfasst von Izabela Tuleta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), Albert Einstein College of Medicine, The Wilf Family Cardiovascular Research Institute, 1300 Morris Park Avenue …. Hauptthemen laut MEDLINE: Fibrosis, Fibroblasts, Signal Transduction, Transforming Growth Factor beta. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, US Department of Defense, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Transforming growth factor (TGF)-β is up-regulated in the diabetic myocardium and may mediate fibroblast activation. We aimed at examining the role of TGF-β-induced fibroblast activation in the pathogenesis of diabetic cardiomyopathy. Methods and results We generated lean and obese db/db mice with fibroblast-specific loss of TbR2, the Type 2 receptor-mediating signaling through all three TGF-β isoforms, and mice with fibroblast-specific Smad3 disruption. Systolic and diastolic function, myocardial fibrosis, and hypertrophy were assessed. Transcriptomic studies and in vitro experiments were used to dissect mechanisms of fibroblast activation. Fibroblast-specific TbR2 loss attenuated systolic and diastolic dysfunction in db/db mice. The protective effects of fibroblast TbR2 loss in db/db mice were associated with attenuated fibrosis and reduced cardiomyocyte hypertrophy, suggesting that in addition to their role in fibrous tissue deposition, TGF-β-stimulated fibroblasts may also exert paracrine actions on cardiomyocytes. Fibroblast-specific Smad3 loss phenocopied the protective effects of fibroblast TbR2 loss in db/db mice. Db/db fibroblasts had increased expression of genes associated with oxidative response (such as Fmo2, encoding flavin-containing monooxygenase 2), matricellular genes (such as Thbs4 and Fbln2), and Lox (encoding lysyl oxidase). Ingenuity pathway analysis (IPA) predicted that neurohumoral mediators, cytokines, and growth factors (such as AGT, TGFB1, and TNF) may serve as important upstream regulators of the transcriptomic profile of diabetic mouse fibroblasts. IPA of scRNA-seq data identified TGFB1, p53, MYC, PDGF-BB, EGFR, and WNT3A/CTNNB1 as important upstream regulators underlying fibroblast activation in db/db hearts. Comparison of the transcriptome of fibroblasts from db/db mice with fibroblast-specific Smad3 loss and db/db Smad3 fl/fl controls identified Thbs4 [encoding thrombospondin-4 (TSP-4), a marker of activated fibroblasts] as a candidate diabetes-induced fibrogenic mediator. However, in vitro experiments showed no significant activating effects of matricellular or intracellular TSP-4 on cardiac fibroblasts.

Conclusion

Fibroblast-specific TGF-β/Smad3 signaling mediates ventricular fibrosis, hypertrophy, and dysfunction in Type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisFibroblastsSignal TransductionTransforming Growth Factor betaDiabetic CardiomyopathiesObesityAnimalsCells, CulturedVentricular Function, LeftMice, Inbred C57BLSmad3 ProteinDisease Models, AnimalVentricular RemodelingMaleMyocardiumVentricular Dysfunction, LeftCardiomegalyMyocytes, CardiacMiceHypertrophy, Left VentricularMice, KnockoutParacrine Communication

Stichwörter der Autor:innen

Diabetic cardiomyopathyFibrosisHeart failureHypertrophyTGF-β

Substanzen

Transforming Growth Factor betaSmad3 ProteinSmad3 protein, mouse

Autor:innen und Institutionen

  • Department of Medicine (Cardiology), Albert Einstein College of Medicine, The Wilf Family Cardiovascular Research Institute, 1300 Morris Park Avenue Forchheimer G46B, Bronx, NY 10461, USA.
  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, The Wilf Family Cardiovascular Research Institute, 1300 Morris Park Avenue Forchheimer G46B, Bronx, NY 10461, USA.
  • Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue Forchheimer G46B, Bronx, NY 10461, USA.

ORCID-Profile: Nikolaos G Frangogiannis

Förderung

  • NIH HHS
  • US Department of Defense
  • American Heart Association
  • American Heart Association-American Stroke Association
  • Career Development
  • Deutsche Forschungsgemeinschaft
  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Tuleta, I., Hanna, A., Humeres, C., Aguilan, J. T., Sidoli, S., Zhu, F., & Frangogiannis, N. G. (2024). Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovascular Research, 120(16), 2047-2063. https://doi.org/10.1093/cvr/cvae210

Vancouver

Tuleta I, Hanna A, Humeres C, Aguilan JT, Sidoli S, Zhu F, et al. Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovascular Research. 2024;120(16):2047-2063. doi:10.1093/cvr/cvae210

BibTeX
@article{Tuleta2024,
  author = {Tuleta, Izabela and Hanna, Anis and Humeres, Claudio and Aguilan, Jennifer T and Sidoli, Simone and Zhu, Fenglan and Frangogiannis, Nikolaos G},
  title = {Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {16},
  pages = {2047--2063},
  doi = {10.1093/cvr/cvae210}
}
Kostenlos starten →